drugset / Trial / NCT00131235

Gestational Sulfadoxine-pyrimethamine and Azithromycin Treatment to Prevent Preterm Birth

NCT00131235 ↗

RandomizedParallel-groupSingle-blindPrevention

Summary

The purpose of this study is to examine whether treatment of pregnant Malawian women with repeated doses of sulfadoxine-pyrimethamine and azithromycin antibiotics will prevent preterm deliveries and result in other health benefits both for the mother and the foetus/newborn.

Timeline

Start
2003-12
Primary completion
2007-06
Completion
2027-12-31

Outcome

Met primary endpoint

paper and 11.8% in AZI-SP group (risk ratio = 0.66, P = 0.01). PMID 21118924 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 1000 mg —
Comparator Sulfadoxine-pyrimethamine Small molecule 1500 mg —